Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
about
Plant expression systems, a budding way to confront chikungunya and Zika in developing countries?Plant-based vaccines against respiratory diseases: current status and future prospects.Depth Filters Containing Diatomite Achieve More Efficient Particle Retention than Filters Solely Containing Cellulose Fibers.Plant-expressed cocaine hydrolase variants of butyrylcholinesterase exhibit altered allosteric effects of cholinesterase activity and increased inhibitor sensitivityA transatlantic perspective on 20 emerging issues in biological engineering.Bioreactor-Based Production of Glycoproteins in Plant Cell Suspension Cultures.
P2860
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@ast
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@en
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@nl
type
label
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@ast
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@en
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@nl
prefLabel
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@ast
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@en
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@nl
P2860
P3181
P1476
Molecular pharming's foot in the FDA's door: Protalix's trailblazing story
@en
P2093
Tsafrir S. Mor
P2860
P2888
P304
P3181
P356
10.1007/S10529-015-1908-Z
P407
P577
2015-11-01T00:00:00Z